BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27717918)

  • 1. Evaluation of mesoporous carbon aerogels as carriers of the non-steroidal anti-inflammatory drug ibuprofen.
    Eleftheriadis GK; Filippousi M; Tsachouridou V; Darda MA; Sygellou L; Kontopoulou I; Bouropoulos N; Steriotis T; Charalambopoulou G; Vizirianakis IS; Van Tendeloo G; Fatouros DG
    Int J Pharm; 2016 Dec; 515(1-2):262-270. PubMed ID: 27717918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.
    Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ
    Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F
    Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery.
    Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen.
    Xin W; Wang Y; Guo X; Gou K; Li J; Li S; Zhao L; Li H
    Int J Nanomedicine; 2020; 15():7451-7468. PubMed ID: 33116481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Carrageenan Aerogel Microparticles as a Potential Drug Carrier.
    Obaidat RM; Alnaief M; Mashaqbeh H
    AAPS PharmSciTech; 2018 Jul; 19(5):2226-2236. PubMed ID: 29736886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
    Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
    Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of alginate-based aerogel for nonsteroidal anti-inflammatory drugs controlled delivery systems using prilling and supercritical-assisted drying.
    Gaudio PD; Auriemma G; Mencherini T; Porta GD; Reverchon E; Aquino RP
    J Pharm Sci; 2013 Jan; 102(1):185-94. PubMed ID: 23150457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High load drug release systems based on carbon porous nanocapsule carriers. Ibuprofen case study.
    Ávila MI; Alonso-Morales N; Baeza JA; Rodríguez JJ; Gilarranz MA
    J Mater Chem B; 2020 Jun; 8(24):5293-5304. PubMed ID: 32452503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen.
    Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z
    J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911
    [No Abstract]   [Full Text] [Related]  

  • 19. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study.
    Zhao P; Wang L; Sun C; Jiang T; Zhang J; Zhang Q; Sun J; Deng Y; Wang S
    Eur J Pharm Biopharm; 2012 Apr; 80(3):535-43. PubMed ID: 22193360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
    Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
    Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.